2096-21-1Relevant articles and documents
CYCLOALKANE-1,3-DIAMINE DERIVATIVE
-
Paragraph 1399-1402, (2021/09/03)
The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.
THERAPEUTIC HYDROXYPYRIDINONES, HYDROXYPYRIMIDINONES AND HYDROXYPYRIDAZINONES
-
Page/Page column 73, (2014/04/03)
The invention provides compounds of formula (I): and salts and prodrugs thereof wherein R4, X1 and X2 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.
On the characterization of 4-nitropyridazine 1-oxide and the N-oxidation of 4-methoxypyridazines.
ITAI,NATSUME
, p. 643 - 645 (2007/10/07)
-